High-pressure Raman spectroscopy has been used to study tris(hydroxymethyl)aminomethane (C(CH(2)OH)(3)NH(2), Tris). Molecules with globular shapes such as Tris have been studied thoroughly as a function of temperature and are of fundamental interest because of the presence of thermal transitions from orientational order to disorder. In contrast, relatively little is known about their high-pressure behavior. Diamond anvil cell techniques were used to generate pressures in Tris samples up to approximately 10 GPa. A phase transition was observed at a pressure of approximately 2 GPa that exhibited relatively slow kinetics and considerable hysteresis, indicative of a first-order transition. The Raman spectrum becomes significantly more complex in the high-pressure phase, indicating increased correlation splitting and significant enhancement in the intensity of some weak, low-pressure phase Raman-active modes.
The pressure/temperature phase diagram of LiAlH 4 has been constructed by using Raman spectroscopy data. In situ high pressure-temperature experiments were carried out using resistively heated diamond anvil cells up to 150 °C and 7 GPa. Room temperature phase transitions of monoclinic R-LiAlH 4 f δ-LiAlH 4 were observed at ∼3.2 GPa. As the temperature is increased to ∼100 °C, both the R and δ phases transform to β-LiAlH 4 and remain stable up to 5.5 GPa. At temperatures greater than 300 °C, a new γ-LiAlH 4 phase forms. Data of Konovalov (1995) has been used to define the phase boundary between βand γ-LiAlH 4 phases. We present a pressure-temperature phase diagram of LiAlH 4 based using diamond anvil cells coupled with Raman spectroscopy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.